1. Medicines
  2. Pain Relief
  3. Headache & Migraine
  4. Migraitan 50mg Tablets 2s
Migraitan 50mg Tablets 2s
up to

Migraitan 50mg Tablets 2s

SKU : OTCMIGRAITAN|PIP-Code : 3884616|EAN : 5060013943003
In Stock
Brand Image
Click on stars to rate this product
Write a review
RRP : £8.00
Add to basket
Migraitan 50mg Tablets are used to treat migraines in adults aged 18-65 who have previously been diagnosed with this condition by a doctor.
Read more about this product »
Caution : This medicine contains the active ingredient Sumatriptan. It is only licensed for use in people who have previously been diagnosed by their GPs as sufferers of migraine(s).
  • Description
  • Directions
  • Ingredients
  • Cautions
  • Patient Information
  • Reviews
Migraitan 50mg Tablets

Migraitan 50mg Tablets are used to treat migraines in adults aged 18-65 who have previously been diagnosed with this condition by a doctor.

Migraine symptoms may be caused by the temporary swelling of blood vessels in the head due to a temporary imbalance in the body's chemicals. Migraitan 50mg Tablets contain sumatriptan which is believed to work on this imbalance and reduce the swelling of these blood vessels. They help to take away the headache and other symptoms of a migraine attack such as nausea and sensitivity to light and sound.
Adults aged 18 to 65:
  • The recommended dose is 50mg Sumatriptan. 
  • Swallow each tablet whole with a glass of water, preferably as soon as possible after onset of the migraine attack.
  • If symptoms are not reduced after the first dose, you may not take a second dose for the same attack. In the event of a subsequent attack, sumatriptan can be taken again. If, after the first dose, your symptoms are reduced, but then return, you may take a second dose within 24 hours, provided you wait at least 2 hours between doses.
  • You must not take more than 300mg of Sumatriptan in any 24-hour period.
  • Active Ingredient: Sumatriptan 50mg (as succinate).
  • Other Ingredients: Lactose monohydrate, microcrystalline cellulose, pregelatinised starch, croscarmellose sodium, magnesium stearate, hypromellose, titanium dioxide (E171), purified talc, Macrogol, iron oxide yellow E172 and iron oxide red E172.
  • Migraitan 50mg Tablets  must only be used if a diagnosis of "migraine" has been clearly established in your case and other factors have been excluded. Certain forms of migraine cannot be treated with this medicine.
  • After taking Migraitan 50mg Tablets you may feel pain in your chest and a feeling of pressure for a short time. This can be quite intensive and may radiate up towards your throat. In very rare cases this may be caused by effects on your heart. Therefore, if the symptoms do not disappear, contact your doctor.
  • Overuse of Migraitan 50mg Tablets may cause chronic, daily headache or worsened headache. Ask your doctor if you think that this is the case for you. It may be necessary to discontinue the treatment with these tablets in order to correct the problem.
  • If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Migraitan 50mg Tablets should be used during the pregnancy only if the potential benefit to the mother outweighs the potential risk to the unborn child and no other appropriate treatment option is available. Migraitan 50mg Tablets pass in to breast milk. You are advised not to breast-feed within 12 hours after taking Sumatriptan. Do not feed your child with milk expressed during this period.
  • No studies on the effects on the ability to drive and use machines have been performed. Drowsiness may occur as a result of migraine or its treatment with sumatriptan and this may influence the ability to drive and to operate machinery.
  • Migraitan 50mg Tablets contain Lactose. If you have been told by your doctor that you have intolerance to some sugars, contact your doctor before taking this medicinal product.
Do not take Migraitan 50mg Tablets:
  • If you are allergic to Sumatriptan or any of the other ingredients.
  • If you have or have ever had heart problems, including a heart attack, angina (chest pain caused by exercise or effort), Prinzmental's angina (chest pain which happens at rest) or have experienced heart related symptoms such as shortness of breath or pressure over the chest.
  • If you have problems with the blood circulation to your hands and feet (peripheral vascular disease).
  • If you have had a stroke/cerebral infarction, also described as an "attack" or cerebral haemorrhage (CVA; cerebrovascular accident).
  • If you have had a temporary disturbance of the blood supply to the brain that left little or no residual symptoms (TIA).
  • If you have severe liver function impairment.
  • If you have high blood pressure.
  • If you are taking drugs containing ergotamine or ergotamine derivatives (migraine drugs such as methysergide) or other triptans (5 hydroxytriptamine (5HT1) receptor agonists, such as almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan or zolmitriptan etc.). These must not be taken at the same time as Sumatriptan.
  • If you are currently taking MAO inhibitors (e.g. moclobemide for depression or selegiline for Parkinsons disease). Sumatriptan must not be used within two weeks of discontinuation of therapy with MAO inhibitors.
Talk to your doctor or pharmacist before taking Migraitan 50mg Tablets if:
  • You are diabetic, especially if you are a woman past the menopause or a man over 40 years. The doctor should examine you first.
  • You are a heavy user of tobacco or products containing nicotine (patches or chewing gum), especially if you are a woman past the menopause or a man over 40 years. The doctor should examine you first.
  • You have liver or kidney impairment. The doctor might adjust the dose
  • You have ever suffered seizures/fits (convulsions) or have a predisposition to seizures/fits (convulsions); Migraitan 50mg Tablets can cause seizures/fits and might increase the risk of seizures.
  • You are hypersensitive to certain antibiotics (sulphonamides). You may experience an allergic reaction after taking Migraitan 50mg Tablets. Caution is advisable.
  • You use herbal products containing St John's Wort (Hypericum perforatum). Side effects may occur with greater frequency.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, particularly:
  • Medicines containing ergotamine (migraine drugs) or other triptans. These must not be taken at the same time as Migraitan 50mg Tablets. After taking medicines containing ergotamine, you are advised to wait at least 24 hours before taking Sumatriptan. After taking Sumatriptan you are advised to wait at least 6 hours before taking medicines containing ergotamine and atleast 24 hours before taking medicines containing other triptans.
  • MAO inhibitors (e.g. moclobemide for depression or selegiline for Parkinson’s disease). Migraitan 50mg Tablets must not be taken within two weeks after stopping use of MAO inhibitors.
  • SSRIs or SNRIs. Use of triptans with antidepressant drugs like Selective serotonin reuptake inhibitors (SSRI) and Serotonin - nor epinephrine reuptake inhibitors (SNRI) may cause serotonin syndrome (a combination of symptoms that may include confusion, hallucination, restlessness, sweating, muscle spasms, and tremors). If you experience these symptoms please tell your doctor.
  • Lithium. There is a risk that concomitant use of Migraitan 50mg Tablets and lithium (for manic depressive (bipolar) disorders) may cause serotonin syndrome. 
Always read the product information. Click on the link below to view the Patient Information Leaflet. Requires Adobe Reader – if you cannot open the file, please click here to download.

PDF Image Patient Information Leaflet
  Average rating (0 reviews) Write a Review
Your recent history